You are here:
Main Content
-
Dr Oliver Schumacher
Dr Oliver Schumacher
Post Doctoral Research Fellow
| Email: | o.schumacher@ecu.edu.au |
|---|---|
| Campus: | Joondalup |
| Room: | JO21.223 |
| ORCID iD: | https://orcid.org/0000-0002-8814-9429 |
Co-lead, Exercise and Genitourinary Cancers Research Group
Oliver is a Cancer Council WA Post-Doctoral Research Fellow at the Exercise Medicine Research Institute in the School of Medical and Health Sciences. Oliver’s research focuses on the role of exercise medicine to reduce the risk of cancer recurrence and improve survival by developing a better understanding of how exercise can influence a patient’s response to treatment.
Background
Oliver completed his PhD in exercise oncology at Edith Cowan University where he investigated the role of exercise as adjunct therapy during treatment for men with prostate cancer. He also has a Bachelor of Science and a Master of Science in Health Sciences and Technology from ETH Zurich (Switzerland).
Professional Memberships
- American College of Sports Medicine (ACSM)
- Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
Awards and Recognition
- 2023 – Prostate Cancer Foundation of Australia Priority Impact Research Award–Future Leaders
- 2022 – Cancer Council WA Post-Doctoral Research Fellowship
- 2021 – Helen Crowe Poster Award (1st Place) at the Asia-Pacific Prostate Cancer Conference
- 2021 – Early Career Researcher Award from the Exercise Medicine Research Institute
- 2019 – Early Career Mentorship Grant from the NHMRC Centre of Research Excellence in Prostate Cancer Survivorship
- 2018 – PhD Scholarship from the NHMRC Centre of Research Excellence in Prostate Cancer Survivorship
- 2017 – Finalist for the Young Investigator Award at EuroPrevent (now ESC Preventive Cardiology)
Research Areas and Interests
- Exercise medicine as adjunct therapy during cancer treatment
- Tumour vascular biology, blood flow and hypoxia
- Patient-reported outcomes and treatment-related toxicity
Qualifications
- Doctor of Philosophy, Edith Cowan University, 2022.
- Masters Degree in Health Sciences and Technology, Switzerland, 2017.
Research Outputs
Journal Articles
- Taaffe, D., McCombie, S., Galvao, D., Newton, R., La Bianca, S., Chambers, S., Spry, N., Singh, F., Lopez Da Cruz, P., Schumacher, O., Hawks, C., Hayne, D. (2023). Efficacy and Feasibility of Presurgical Exercise in Bladder Cancer Patients Scheduled for Open Radical Cystectomy. Medicine and Science in Sports and Exercise, 55(7), 1123-1132. https://doi.org/10.1249/MSS.0000000000003137.
Journal Articles
- Schumacher, O., Galvao, D., Taaffe, D., Spry, N., Hayne, D., Tang, C., Chee, R., Newton, R. (2022). Nationwide Industry-Led Community Exercise Program for Men With Locally Advanced, Relapsed, or Metastatic Prostate Cancer on Androgen-Deprivation Therapy. JCO Oncology Practice, 18(8), e1334–e1341. https://doi.org/10.1200/OP.21.00745.
- Luo, H., Schumacher, O., Galvao, D., Newton, R., Taaffe, D. (2022). Adverse Events Reporting of Clinical Trials in Exercise Oncology Research (ADVANCE): Protocol for a Scoping Review. Frontiers in Oncology, 12(16 February 2022), Article number 841266. https://doi.org/10.3389/fonc.2022.841266.
Journal Articles
- Schumacher, O., Galvao, D., Taaffe, D., Chee, R., Spry, N., Newton, R. (2021). Exercise modulation of tumour perfusion and hypoxia to improve radiotherapy response in prostate cancer. Prostate Cancer and Prostatic Diseases, 24(1), 1-14. https://doi.org/10.1038/s41391-020-0245-z.
- Schumacher, O., Galvao, D., Taaffe, D., Spry, N., Joseph, D., Tang, C., Chee, R., Newton, R. (2021). Effect of Exercise Adjunct to Radiation and Androgen Deprivation Therapy on Patient-Reported Treatment Toxicity in Men With Prostate Cancer: A Secondary Analysis of 2 Randomized Controlled Trials. Practical Radiation Oncology, 11(3), 215-225. https://doi.org/10.1016/j.prro.2021.01.005.
- Schumacher, O., Luo, H., Taaffe, D., Galvao, D., Tang, C., Chee, R., Spry, N., Newton, R. (2021). Effects of exercise during radiotherapy on physical function and treatment-related side effects in men with prostate cancer: A systematic review and meta-analysis. International Journal of Radiation: Oncology - Biology - Physics, 111(3), 716-731. https://doi.org/10.1016/j.ijrobp.2021.06.034.
Research Projects
- Exercise medicine as adjunct therapy during RADIation for CAncer of the prostaTE to improve treatment efficacy – the ERADICATE study: a phase II randomised controlled trial, World Cancer Research Fund, Investigator initiated grants, 2024 ‑ 2027, $534,961.
- Can exercise reduce the symptom burden and improve tumour blood flow to increase treatment efficacy in men with prostate cancer undergoing radiotherapy?, Cancer Council of WA Inc, Postdoctoral Fellowship, 2023 ‑ 2026, $445,166.
- Exercise as a novel therapeutic approach for sensitising prostate cancer to radiotherapy, Cancer Australia, Priority-driven Collaborative Cancer Research Scheme, 2024, $97,665.
- Exercise medicine for men with prostate cancer during radiotherapy, Prostate Cancer Foundation of Australia, Priority Impact Research Awards - Future Leaders, 2022 ‑ 2023, $100,000.